Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cholera | 118 | 2024 | 747 | 16.790 |
Why?
|
Vibrio cholerae O1 | 52 | 2024 | 243 | 10.100 |
Why?
|
Antibodies, Bacterial | 85 | 2024 | 1469 | 9.990 |
Why?
|
Cholera Vaccines | 49 | 2024 | 262 | 9.730 |
Why?
|
O Antigens | 26 | 2024 | 196 | 7.860 |
Why?
|
Typhoid Fever | 30 | 2023 | 194 | 6.270 |
Why?
|
Vibrio cholerae | 56 | 2023 | 793 | 5.550 |
Why?
|
Salmonella typhi | 25 | 2023 | 198 | 5.270 |
Why?
|
Travel | 41 | 2024 | 796 | 4.360 |
Why?
|
Bangladesh | 79 | 2023 | 736 | 3.570 |
Why?
|
Vaccines, Conjugate | 14 | 2024 | 328 | 3.550 |
Why?
|
Immunoglobulin A | 51 | 2024 | 978 | 3.470 |
Why?
|
Dysentery, Bacillary | 7 | 2024 | 73 | 3.300 |
Why?
|
Vibrio cholerae O139 | 14 | 2023 | 54 | 2.990 |
Why?
|
Diarrhea | 31 | 2024 | 1318 | 2.870 |
Why?
|
Immunologic Memory | 27 | 2022 | 1359 | 2.600 |
Why?
|
Antigens, Bacterial | 24 | 2022 | 1155 | 2.580 |
Why?
|
Immunoglobulin M | 27 | 2024 | 1527 | 2.410 |
Why?
|
Immunoglobulin G | 62 | 2024 | 4544 | 2.380 |
Why?
|
Vaccination | 38 | 2024 | 3384 | 2.290 |
Why?
|
Shigella Vaccines | 3 | 2024 | 10 | 1.940 |
Why?
|
Immunity, Mucosal | 11 | 2020 | 483 | 1.840 |
Why?
|
Cholera Toxin | 34 | 2024 | 559 | 1.830 |
Why?
|
Salmonella paratyphi A | 8 | 2017 | 47 | 1.700 |
Why?
|
Travel Medicine | 9 | 2023 | 83 | 1.650 |
Why?
|
Paratyphoid Fever | 6 | 2016 | 34 | 1.540 |
Why?
|
Typhoid-Paratyphoid Vaccines | 3 | 2020 | 39 | 1.490 |
Why?
|
Bacteremia | 12 | 2015 | 979 | 1.460 |
Why?
|
B-Lymphocytes | 26 | 2022 | 4758 | 1.380 |
Why?
|
Shigella flexneri | 4 | 2024 | 119 | 1.360 |
Why?
|
Shigella | 5 | 2023 | 68 | 1.320 |
Why?
|
Immunity, Humoral | 5 | 2020 | 606 | 1.320 |
Why?
|
Lipopolysaccharides | 22 | 2024 | 2206 | 1.280 |
Why?
|
Communicable Disease Control | 10 | 2024 | 846 | 1.180 |
Why?
|
Antibody-Producing Cells | 10 | 2021 | 140 | 1.070 |
Why?
|
Endemic Diseases | 3 | 2024 | 190 | 1.010 |
Why?
|
Feces | 20 | 2024 | 1497 | 0.980 |
Why?
|
Blood Group Antigens | 4 | 2023 | 184 | 0.980 |
Why?
|
Parasitic Diseases | 4 | 2021 | 76 | 0.980 |
Why?
|
Antibody Formation | 12 | 2024 | 1395 | 0.970 |
Why?
|
Disease Outbreaks | 15 | 2020 | 1749 | 0.960 |
Why?
|
Shigella sonnei | 1 | 2024 | 7 | 0.960 |
Why?
|
Salmonella Infections | 3 | 2015 | 172 | 0.940 |
Why?
|
Vaccines, Combined | 2 | 2021 | 70 | 0.930 |
Why?
|
Diarrhea, Infantile | 2 | 2015 | 100 | 0.920 |
Why?
|
Escherichia coli Infections | 7 | 2018 | 518 | 0.900 |
Why?
|
Child, Preschool | 74 | 2024 | 42230 | 0.900 |
Why?
|
Communicable Diseases | 10 | 2018 | 875 | 0.890 |
Why?
|
Serologic Tests | 5 | 2020 | 381 | 0.870 |
Why?
|
Carrier State | 4 | 2021 | 523 | 0.860 |
Why?
|
Antibodies, Viral | 16 | 2023 | 3156 | 0.840 |
Why?
|
Bacterial Proteins | 13 | 2022 | 3847 | 0.770 |
Why?
|
Tetanus Toxin | 3 | 2023 | 46 | 0.760 |
Why?
|
Mucous Membrane | 5 | 2019 | 659 | 0.740 |
Why?
|
Virus Diseases | 4 | 2021 | 718 | 0.730 |
Why?
|
Child | 86 | 2024 | 80153 | 0.730 |
Why?
|
Administration, Oral | 22 | 2021 | 4021 | 0.720 |
Why?
|
Vaccines, Inactivated | 13 | 2023 | 179 | 0.720 |
Why?
|
Salmonella | 4 | 2022 | 125 | 0.700 |
Why?
|
Fever | 5 | 2024 | 1618 | 0.700 |
Why?
|
Host-Pathogen Interactions | 6 | 2021 | 1459 | 0.690 |
Why?
|
Humans | 266 | 2024 | 761504 | 0.690 |
Why?
|
Bacterial Vaccines | 6 | 2009 | 401 | 0.680 |
Why?
|
Enterotoxigenic Escherichia coli | 6 | 2018 | 32 | 0.670 |
Why?
|
Drug Resistance, Multiple, Bacterial | 3 | 2019 | 587 | 0.650 |
Why?
|
Vitreous Body | 3 | 2010 | 399 | 0.620 |
Why?
|
Adolescent | 89 | 2024 | 88319 | 0.620 |
Why?
|
Young Adult | 73 | 2024 | 59243 | 0.580 |
Why?
|
Measles | 4 | 2022 | 183 | 0.580 |
Why?
|
Enterotoxins | 5 | 2016 | 367 | 0.570 |
Why?
|
Endophthalmitis | 3 | 2010 | 260 | 0.560 |
Why?
|
Adult | 122 | 2024 | 221177 | 0.550 |
Why?
|
Antifungal Agents | 1 | 2022 | 752 | 0.550 |
Why?
|
Dehydration | 4 | 2022 | 216 | 0.550 |
Why?
|
Disease Transmission, Infectious | 3 | 2018 | 559 | 0.540 |
Why?
|
Vaccines | 6 | 2023 | 844 | 0.530 |
Why?
|
Headache | 1 | 2024 | 1256 | 0.510 |
Why?
|
Disasters | 3 | 2006 | 519 | 0.510 |
Why?
|
Measles-Mumps-Rubella Vaccine | 4 | 2022 | 72 | 0.510 |
Why?
|
Immunization | 9 | 2020 | 1228 | 0.510 |
Why?
|
Rubella | 3 | 2022 | 55 | 0.510 |
Why?
|
Mumps | 3 | 2022 | 71 | 0.490 |
Why?
|
Female | 140 | 2024 | 392644 | 0.490 |
Why?
|
Plasma | 1 | 2018 | 586 | 0.480 |
Why?
|
Anti-Bacterial Agents | 18 | 2023 | 7407 | 0.470 |
Why?
|
Vaccines, Attenuated | 7 | 2022 | 315 | 0.470 |
Why?
|
Bacterial Toxins | 6 | 2016 | 931 | 0.460 |
Why?
|
Entamoebiasis | 1 | 2013 | 12 | 0.450 |
Why?
|
Campylobacter Infections | 1 | 2013 | 31 | 0.450 |
Why?
|
Vaccines, Synthetic | 7 | 2022 | 616 | 0.450 |
Why?
|
Fimbriae Proteins | 8 | 2015 | 132 | 0.450 |
Why?
|
Molecular Diagnostic Techniques | 2 | 2016 | 611 | 0.440 |
Why?
|
Male | 124 | 2024 | 360804 | 0.440 |
Why?
|
Pandemics | 12 | 2021 | 8654 | 0.440 |
Why?
|
Infant | 41 | 2022 | 36192 | 0.430 |
Why?
|
Eye Diseases | 2 | 2009 | 653 | 0.430 |
Why?
|
Islam | 1 | 2014 | 70 | 0.430 |
Why?
|
Yellow Fever | 3 | 2021 | 54 | 0.420 |
Why?
|
RNA, Bacterial | 2 | 2011 | 393 | 0.420 |
Why?
|
Enterobacteriaceae | 4 | 2023 | 161 | 0.420 |
Why?
|
Blood | 4 | 2016 | 596 | 0.420 |
Why?
|
Gallbladder | 1 | 2014 | 308 | 0.420 |
Why?
|
Biliary Tract | 1 | 2013 | 135 | 0.410 |
Why?
|
Retinal Diseases | 2 | 2009 | 705 | 0.410 |
Why?
|
Rotavirus Infections | 1 | 2013 | 84 | 0.410 |
Why?
|
Sarcocystidae | 1 | 2011 | 2 | 0.400 |
Why?
|
Leukocytes, Mononuclear | 4 | 2017 | 1844 | 0.400 |
Why?
|
Coccidiosis | 1 | 2011 | 10 | 0.400 |
Why?
|
Public Health Administration | 2 | 2013 | 242 | 0.390 |
Why?
|
Bacterial Infections | 3 | 2017 | 1390 | 0.380 |
Why?
|
Administration, Cutaneous | 5 | 2020 | 713 | 0.380 |
Why?
|
Mice | 26 | 2024 | 81525 | 0.380 |
Why?
|
Haiti | 9 | 2019 | 550 | 0.370 |
Why?
|
Gastroenteritis | 1 | 2013 | 236 | 0.370 |
Why?
|
Antibodies, Protozoan | 4 | 2012 | 252 | 0.360 |
Why?
|
Animals | 44 | 2024 | 168459 | 0.360 |
Why?
|
Glycoconjugates | 2 | 2023 | 88 | 0.350 |
Why?
|
Middle Aged | 74 | 2022 | 220895 | 0.350 |
Why?
|
Antibodies, Monoclonal | 4 | 2021 | 9177 | 0.350 |
Why?
|
Basketball | 2 | 2021 | 46 | 0.340 |
Why?
|
Genome, Bacterial | 5 | 2024 | 783 | 0.340 |
Why?
|
Family Characteristics | 8 | 2018 | 1004 | 0.340 |
Why?
|
Malaria | 7 | 2017 | 1227 | 0.340 |
Why?
|
Cryptosporidiosis | 4 | 2012 | 52 | 0.340 |
Why?
|
Lymphocytes | 4 | 2022 | 2612 | 0.340 |
Why?
|
Immunoassay | 3 | 2020 | 745 | 0.330 |
Why?
|
Drug Resistance, Bacterial | 4 | 2020 | 1048 | 0.320 |
Why?
|
Salmonella typhimurium | 2 | 2009 | 347 | 0.320 |
Why?
|
Convalescence | 3 | 2021 | 105 | 0.320 |
Why?
|
Immunization Programs | 2 | 2018 | 268 | 0.310 |
Why?
|
Antimalarials | 5 | 2016 | 907 | 0.310 |
Why?
|
Internationality | 4 | 2024 | 1001 | 0.310 |
Why?
|
Anti-Infective Agents | 3 | 2023 | 983 | 0.300 |
Why?
|
Antibodies, Neutralizing | 6 | 2022 | 1943 | 0.290 |
Why?
|
Blood Bactericidal Activity | 6 | 2015 | 124 | 0.290 |
Why?
|
Bacillus anthracis | 1 | 2008 | 122 | 0.290 |
Why?
|
Fasting | 1 | 2014 | 1603 | 0.290 |
Why?
|
Asia | 3 | 2018 | 619 | 0.290 |
Why?
|
Yellow Fever Vaccine | 2 | 2021 | 37 | 0.290 |
Why?
|
Vitrectomy | 1 | 2010 | 392 | 0.290 |
Why?
|
Leptin | 1 | 2015 | 1597 | 0.280 |
Why?
|
Schistosomiasis mansoni | 1 | 2007 | 93 | 0.280 |
Why?
|
Fungemia | 1 | 2007 | 57 | 0.270 |
Why?
|
Gene Expression Regulation, Bacterial | 3 | 2015 | 1133 | 0.270 |
Why?
|
Interferon-gamma | 2 | 2014 | 3162 | 0.270 |
Why?
|
Cryptosporidium | 4 | 2012 | 41 | 0.270 |
Why?
|
Neuraminidase | 3 | 2022 | 196 | 0.270 |
Why?
|
Shigella dysenteriae | 1 | 2005 | 14 | 0.270 |
Why?
|
Eye Infections, Bacterial | 2 | 2007 | 242 | 0.260 |
Why?
|
Intestinal Diseases | 3 | 2016 | 504 | 0.260 |
Why?
|
Disease Models, Animal | 10 | 2023 | 18252 | 0.260 |
Why?
|
Gastrointestinal Tract | 3 | 2024 | 833 | 0.260 |
Why?
|
Gene Expression Profiling | 9 | 2018 | 9420 | 0.260 |
Why?
|
Escherichia coli | 7 | 2023 | 4217 | 0.260 |
Why?
|
Coronavirus Infections | 5 | 2020 | 3084 | 0.260 |
Why?
|
Proteome | 2 | 2013 | 1862 | 0.260 |
Why?
|
Duodenum | 5 | 2022 | 490 | 0.260 |
Why?
|
Mice, Inbred BALB C | 5 | 2024 | 6216 | 0.260 |
Why?
|
Pneumonia, Viral | 5 | 2020 | 3204 | 0.260 |
Why?
|
Proteomics | 6 | 2022 | 3849 | 0.260 |
Why?
|
Salmonella enterica | 2 | 2016 | 76 | 0.260 |
Why?
|
Eye Infections, Fungal | 1 | 2007 | 100 | 0.260 |
Why?
|
Onchocerciasis | 1 | 2005 | 28 | 0.250 |
Why?
|
Immunization Schedule | 3 | 2023 | 227 | 0.250 |
Why?
|
Suture Techniques | 1 | 2010 | 769 | 0.250 |
Why?
|
T-Lymphocytes | 6 | 2021 | 10194 | 0.250 |
Why?
|
Lung Abscess | 1 | 2005 | 40 | 0.250 |
Why?
|
Hemolytic-Uremic Syndrome | 1 | 2005 | 106 | 0.250 |
Why?
|
Magnetite Nanoparticles | 2 | 2017 | 318 | 0.250 |
Why?
|
Weather | 1 | 2006 | 231 | 0.250 |
Why?
|
Escherichia coli Proteins | 5 | 2016 | 1067 | 0.250 |
Why?
|
Immunoglobulin A, Secretory | 2 | 2003 | 104 | 0.250 |
Why?
|
Chromatography, Affinity | 3 | 2020 | 532 | 0.240 |
Why?
|
Microsurgery | 1 | 2010 | 795 | 0.240 |
Why?
|
Insect Bites and Stings | 2 | 2018 | 71 | 0.240 |
Why?
|
Treatment Refusal | 3 | 2017 | 429 | 0.240 |
Why?
|
Intestines | 7 | 2016 | 1909 | 0.240 |
Why?
|
Immunologic Techniques | 1 | 2005 | 212 | 0.240 |
Why?
|
Bacteriological Techniques | 2 | 2018 | 275 | 0.240 |
Why?
|
Specimen Handling | 2 | 2020 | 702 | 0.240 |
Why?
|
Pakistan | 3 | 2023 | 292 | 0.230 |
Why?
|
Brain Abscess | 1 | 2005 | 120 | 0.230 |
Why?
|
Rabbits | 6 | 2023 | 4772 | 0.230 |
Why?
|
Health Knowledge, Attitudes, Practice | 6 | 2024 | 4016 | 0.230 |
Why?
|
Pneumonia, Aspiration | 1 | 2005 | 146 | 0.230 |
Why?
|
Enterobacteriaceae Infections | 2 | 2023 | 188 | 0.230 |
Why?
|
Helicobacter pylori | 1 | 2007 | 377 | 0.230 |
Why?
|
Antibody Affinity | 3 | 2014 | 246 | 0.230 |
Why?
|
Paresis | 1 | 2005 | 176 | 0.230 |
Why?
|
Helicobacter Infections | 1 | 2007 | 388 | 0.230 |
Why?
|
Occupational Health | 2 | 2016 | 806 | 0.220 |
Why?
|
Colistin | 2 | 2023 | 44 | 0.220 |
Why?
|
Disease Susceptibility | 4 | 2021 | 1787 | 0.220 |
Why?
|
Hafnia | 1 | 2023 | 3 | 0.220 |
Why?
|
Pneumonia | 1 | 2015 | 2143 | 0.220 |
Why?
|
Lymphocyte Activation | 1 | 2014 | 5486 | 0.220 |
Why?
|
Echinococcosis, Pulmonary | 1 | 2003 | 7 | 0.220 |
Why?
|
Yersinia pestis | 1 | 2003 | 33 | 0.220 |
Why?
|
Plague | 1 | 2003 | 20 | 0.220 |
Why?
|
Antitoxins | 3 | 2019 | 77 | 0.210 |
Why?
|
Phylogeny | 6 | 2024 | 2811 | 0.210 |
Why?
|
Syphilis | 1 | 2005 | 243 | 0.210 |
Why?
|
United States | 28 | 2024 | 72334 | 0.210 |
Why?
|
Carbapenems | 2 | 2023 | 123 | 0.210 |
Why?
|
Antibody Specificity | 4 | 2021 | 1060 | 0.210 |
Why?
|
Patient Acceptance of Health Care | 3 | 2013 | 3205 | 0.200 |
Why?
|
Bioterrorism | 1 | 2003 | 144 | 0.200 |
Why?
|
Enzyme-Linked Immunospot Assay | 3 | 2017 | 123 | 0.200 |
Why?
|
Peru | 2 | 2024 | 891 | 0.200 |
Why?
|
Antigens, Protozoan | 3 | 2012 | 316 | 0.200 |
Why?
|
Genetic Vectors | 4 | 2000 | 3395 | 0.200 |
Why?
|
Quarantine | 1 | 2024 | 181 | 0.200 |
Why?
|
Seasons | 3 | 2023 | 1520 | 0.200 |
Why?
|
History, 21st Century | 3 | 2018 | 1567 | 0.190 |
Why?
|
Protein Array Analysis | 2 | 2013 | 400 | 0.190 |
Why?
|
Adjuvants, Immunologic | 3 | 2020 | 1036 | 0.190 |
Why?
|
T-Lymphocyte Subsets | 3 | 2018 | 1802 | 0.190 |
Why?
|
Developing Countries | 9 | 2014 | 2885 | 0.190 |
Why?
|
Adhesins, Bacterial | 2 | 1999 | 118 | 0.190 |
Why?
|
Entamoeba histolytica | 2 | 2000 | 29 | 0.190 |
Why?
|
Sensitivity and Specificity | 13 | 2020 | 14666 | 0.190 |
Why?
|
Anthozoa | 1 | 2021 | 66 | 0.190 |
Why?
|
Agglutination | 1 | 2020 | 41 | 0.190 |
Why?
|
Cross Reactions | 5 | 2022 | 817 | 0.190 |
Why?
|
Primary Health Care | 1 | 2018 | 4686 | 0.190 |
Why?
|
Animals, Suckling | 1 | 2020 | 69 | 0.190 |
Why?
|
Eosinophilia | 1 | 2005 | 560 | 0.180 |
Why?
|
Immunity, Innate | 4 | 2019 | 3065 | 0.180 |
Why?
|
Immunoglobulin Isotypes | 1 | 2021 | 158 | 0.180 |
Why?
|
RNA, Messenger | 7 | 2023 | 12795 | 0.180 |
Why?
|
Altitude Sickness | 2 | 2018 | 91 | 0.180 |
Why?
|
Immunization, Secondary | 2 | 2021 | 367 | 0.180 |
Why?
|
Hemolysin Proteins | 2 | 2017 | 113 | 0.180 |
Why?
|
Diagnosis, Differential | 9 | 2021 | 12974 | 0.180 |
Why?
|
Nucleocapsid Proteins | 1 | 2020 | 76 | 0.180 |
Why?
|
Neurocysticercosis | 1 | 2021 | 91 | 0.180 |
Why?
|
Shiga Toxins | 2 | 1999 | 40 | 0.180 |
Why?
|
Peroxidase | 2 | 2021 | 609 | 0.180 |
Why?
|
Contact Tracing | 2 | 2014 | 271 | 0.170 |
Why?
|
Genetic Variation | 4 | 2024 | 6567 | 0.170 |
Why?
|
Plasmids | 3 | 2017 | 2269 | 0.170 |
Why?
|
Chemoprevention | 3 | 2023 | 326 | 0.170 |
Why?
|
Athletic Injuries | 2 | 2021 | 1216 | 0.170 |
Why?
|
Glutamate-Ammonia Ligase | 1 | 2000 | 75 | 0.170 |
Why?
|
Interleukin-23 Subunit p19 | 1 | 2019 | 23 | 0.170 |
Why?
|
Hospitals | 7 | 2020 | 3882 | 0.170 |
Why?
|
Laboratories, Hospital | 1 | 2021 | 192 | 0.170 |
Why?
|
Accidents, Traffic | 2 | 2018 | 816 | 0.170 |
Why?
|
Serotyping | 4 | 2015 | 325 | 0.170 |
Why?
|
Metagenomics | 2 | 2021 | 467 | 0.170 |
Why?
|
Tuberculosis, Cutaneous | 1 | 2019 | 17 | 0.160 |
Why?
|
Intestinal Mucosa | 4 | 2022 | 3032 | 0.160 |
Why?
|
Microbial Viability | 4 | 2020 | 238 | 0.160 |
Why?
|
Nepal | 3 | 2018 | 305 | 0.160 |
Why?
|
Microbial Sensitivity Tests | 5 | 2023 | 1937 | 0.160 |
Why?
|
Antigens | 1 | 2005 | 1443 | 0.160 |
Why?
|
Health Behavior | 1 | 2010 | 2643 | 0.160 |
Why?
|
Polysaccharides, Bacterial | 2 | 2020 | 578 | 0.160 |
Why?
|
Antibiosis | 1 | 2018 | 45 | 0.160 |
Why?
|
Preventive Medicine | 1 | 2000 | 246 | 0.160 |
Why?
|
Ambulatory Care Facilities | 2 | 2023 | 935 | 0.150 |
Why?
|
Lung | 3 | 2007 | 10000 | 0.150 |
Why?
|
Molecular Epidemiology | 2 | 2018 | 469 | 0.150 |
Why?
|
Immune Evasion | 1 | 2022 | 363 | 0.150 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2023 | 506 | 0.150 |
Why?
|
Clinical Laboratory Techniques | 2 | 2020 | 746 | 0.150 |
Why?
|
History, 20th Century | 2 | 2018 | 2767 | 0.150 |
Why?
|
Barotrauma | 1 | 2018 | 39 | 0.150 |
Why?
|
Food Safety | 1 | 2018 | 22 | 0.150 |
Why?
|
Desiccation | 1 | 2018 | 78 | 0.150 |
Why?
|
Phosphotransferases (Nitrogenous Group Acceptor) | 1 | 2017 | 5 | 0.150 |
Why?
|
Protozoan Vaccines | 1 | 1997 | 13 | 0.150 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2009 | 3492 | 0.150 |
Why?
|
Ships | 1 | 2018 | 53 | 0.150 |
Why?
|
Retina | 1 | 2009 | 2659 | 0.150 |
Why?
|
Nucleic Acid Amplification Techniques | 2 | 2021 | 330 | 0.150 |
Why?
|
Molecular Typing | 2 | 2015 | 116 | 0.150 |
Why?
|
Phosphoenolpyruvate Sugar Phosphotransferase System | 1 | 2017 | 23 | 0.150 |
Why?
|
Cervix Uteri | 1 | 2001 | 570 | 0.150 |
Why?
|
Athletic Performance | 1 | 2018 | 111 | 0.140 |
Why?
|
Receptors, IgG | 1 | 2020 | 559 | 0.140 |
Why?
|
Pneumonia, Bacterial | 1 | 2000 | 316 | 0.140 |
Why?
|
Cyclobutanes | 1 | 2017 | 57 | 0.140 |
Why?
|
Aircraft | 1 | 2018 | 130 | 0.140 |
Why?
|
Genome, Viral | 1 | 2020 | 667 | 0.140 |
Why?
|
Insect Repellents | 1 | 2016 | 17 | 0.140 |
Why?
|
Zoonoses | 1 | 2018 | 179 | 0.140 |
Why?
|
Mosquito Nets | 1 | 2016 | 9 | 0.140 |
Why?
|
Flagellin | 1 | 2017 | 124 | 0.140 |
Why?
|
Antigens, Viral | 1 | 2020 | 988 | 0.140 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2019 | 416 | 0.130 |
Why?
|
Bacterial Typing Techniques | 2 | 2014 | 263 | 0.130 |
Why?
|
beta-Lactamases | 3 | 2023 | 304 | 0.130 |
Why?
|
Medicine | 2 | 2023 | 942 | 0.130 |
Why?
|
Protective Clothing | 1 | 2016 | 103 | 0.130 |
Why?
|
North America | 1 | 2019 | 1276 | 0.130 |
Why?
|
Risk Factors | 17 | 2023 | 74206 | 0.130 |
Why?
|
Influenza Vaccines | 1 | 2023 | 768 | 0.130 |
Why?
|
Eye Infections, Parasitic | 1 | 1996 | 26 | 0.130 |
Why?
|
HLA-DR Antigens | 1 | 2017 | 602 | 0.130 |
Why?
|
Risk Assessment | 12 | 2018 | 23995 | 0.130 |
Why?
|
Health Services Misuse | 1 | 2017 | 244 | 0.130 |
Why?
|
Hybridization, Genetic | 1 | 2015 | 103 | 0.130 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2020 | 4575 | 0.130 |
Why?
|
Geography | 1 | 2018 | 656 | 0.130 |
Why?
|
DNA Probes | 1 | 2016 | 541 | 0.130 |
Why?
|
Geographic Information Systems | 1 | 2018 | 281 | 0.130 |
Why?
|
Age Factors | 5 | 2021 | 18395 | 0.130 |
Why?
|
Cost-Benefit Analysis | 5 | 2022 | 5492 | 0.130 |
Why?
|
Sexually Transmitted Diseases | 2 | 2018 | 662 | 0.130 |
Why?
|
Immunologic Tests | 1 | 2016 | 104 | 0.130 |
Why?
|
Integrin beta Chains | 1 | 2015 | 115 | 0.130 |
Why?
|
Infant, Newborn | 13 | 2024 | 26198 | 0.130 |
Why?
|
Probiotics | 1 | 2019 | 378 | 0.120 |
Why?
|
Severity of Illness Index | 7 | 2022 | 15842 | 0.120 |
Why?
|
Infant Nutrition Disorders | 1 | 2015 | 70 | 0.120 |
Why?
|
Dominican Republic | 2 | 2012 | 76 | 0.120 |
Why?
|
Bacterial Shedding | 1 | 2014 | 10 | 0.120 |
Why?
|
Japanese Encephalitis Vaccines | 1 | 2014 | 7 | 0.120 |
Why?
|
Case-Control Studies | 9 | 2019 | 22176 | 0.120 |
Why?
|
Encephalitis Virus, Japanese | 1 | 2014 | 12 | 0.120 |
Why?
|
Anterior Eye Segment | 1 | 1996 | 143 | 0.120 |
Why?
|
Encephalitis, Japanese | 1 | 2014 | 13 | 0.120 |
Why?
|
Aged | 26 | 2024 | 169289 | 0.120 |
Why?
|
Echinococcosis, Hepatic | 1 | 2014 | 24 | 0.120 |
Why?
|
Epidemics | 2 | 2018 | 512 | 0.120 |
Why?
|
Albendazole | 1 | 2014 | 50 | 0.120 |
Why?
|
Dengue | 1 | 2017 | 254 | 0.120 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily B | 1 | 2014 | 84 | 0.120 |
Why?
|
Acute Disease | 6 | 2018 | 7237 | 0.120 |
Why?
|
Rabies Vaccines | 1 | 2013 | 27 | 0.110 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 7 | 2020 | 3810 | 0.110 |
Why?
|
Leisure Activities | 1 | 2016 | 308 | 0.110 |
Why?
|
Cohort Studies | 16 | 2022 | 41487 | 0.110 |
Why?
|
Exanthema | 1 | 2019 | 503 | 0.110 |
Why?
|
Recombinant Fusion Proteins | 2 | 2020 | 3734 | 0.110 |
Why?
|
Haplotypes | 2 | 2018 | 2713 | 0.110 |
Why?
|
Lectins | 1 | 2016 | 491 | 0.110 |
Why?
|
History, 16th Century | 1 | 2013 | 70 | 0.110 |
Why?
|
Serum Albumin, Bovine | 2 | 2017 | 321 | 0.110 |
Why?
|
Rabies | 1 | 2013 | 54 | 0.110 |
Why?
|
Skin Diseases | 1 | 2002 | 1094 | 0.110 |
Why?
|
History, 17th Century | 1 | 2013 | 108 | 0.110 |
Why?
|
Hospitalization | 5 | 2021 | 10723 | 0.110 |
Why?
|
Peptides | 2 | 2020 | 4358 | 0.110 |
Why?
|
AIDS Vaccines | 1 | 2020 | 896 | 0.110 |
Why?
|
Protozoan Proteins | 2 | 2011 | 847 | 0.110 |
Why?
|
Occupational Exposure | 1 | 2004 | 1813 | 0.110 |
Why?
|
Recombinant Proteins | 4 | 2016 | 6534 | 0.110 |
Why?
|
Prophages | 1 | 2013 | 39 | 0.110 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2018 | 974 | 0.110 |
Why?
|
History, 18th Century | 1 | 2013 | 207 | 0.110 |
Why?
|
Child Nutrition Disorders | 1 | 2014 | 151 | 0.110 |
Why?
|
Biosensing Techniques | 2 | 2017 | 650 | 0.110 |
Why?
|
Rural Population | 3 | 2018 | 2285 | 0.110 |
Why?
|
Peptide Hydrolases | 1 | 2016 | 624 | 0.100 |
Why?
|
Nucleic Acids | 1 | 2015 | 188 | 0.100 |
Why?
|
Time Factors | 12 | 2020 | 39967 | 0.100 |
Why?
|
Pregnant Women | 1 | 2017 | 566 | 0.100 |
Why?
|
Family Health | 3 | 2018 | 1257 | 0.100 |
Why?
|
Pancreatitis, Acute Necrotizing | 1 | 2014 | 173 | 0.100 |
Why?
|
HIV Infections | 3 | 2017 | 17351 | 0.100 |
Why?
|
Bayes Theorem | 2 | 2022 | 2330 | 0.100 |
Why?
|
Gastrointestinal Diseases | 1 | 2021 | 1200 | 0.100 |
Why?
|
Environmental Illness | 1 | 2012 | 34 | 0.100 |
Why?
|
DNA-Directed DNA Polymerase | 1 | 2015 | 489 | 0.100 |
Why?
|
Cholecystectomy | 1 | 2014 | 406 | 0.100 |
Why?
|
Influenza, Human | 1 | 2023 | 1521 | 0.100 |
Why?
|
Protozoan Infections | 1 | 2011 | 38 | 0.100 |
Why?
|
Urban Population | 3 | 2015 | 2036 | 0.100 |
Why?
|
Virulence | 3 | 2015 | 1303 | 0.100 |
Why?
|
Health Planning Guidelines | 1 | 2012 | 151 | 0.100 |
Why?
|
Neutralization Tests | 2 | 2020 | 728 | 0.100 |
Why?
|
Viral Load | 4 | 2022 | 3332 | 0.100 |
Why?
|
Ileus | 1 | 2011 | 66 | 0.100 |
Why?
|
Immunocompromised Host | 2 | 2015 | 856 | 0.100 |
Why?
|
Incidence | 8 | 2022 | 21353 | 0.100 |
Why?
|
Aged, 80 and over | 12 | 2020 | 58976 | 0.090 |
Why?
|
Point-of-Care Systems | 1 | 2020 | 1213 | 0.090 |
Why?
|
Sanitation | 1 | 2011 | 85 | 0.090 |
Why?
|
Cholecystitis | 1 | 1992 | 180 | 0.090 |
Why?
|
Malnutrition | 2 | 2014 | 645 | 0.090 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2017 | 832 | 0.090 |
Why?
|
Rivers | 2 | 2013 | 64 | 0.090 |
Why?
|
History, 19th Century | 1 | 2013 | 720 | 0.090 |
Why?
|
Safety | 1 | 2015 | 1150 | 0.090 |
Why?
|
Immunodominant Epitopes | 1 | 2012 | 239 | 0.090 |
Why?
|
Ciprofloxacin | 1 | 2013 | 312 | 0.090 |
Why?
|
Plasmodium falciparum | 1 | 2001 | 1742 | 0.090 |
Why?
|
Germ-Free Life | 3 | 2000 | 189 | 0.090 |
Why?
|
Mass Spectrometry | 2 | 2010 | 2192 | 0.090 |
Why?
|
Hypokalemia | 1 | 2011 | 153 | 0.090 |
Why?
|
Aviation | 1 | 2010 | 49 | 0.090 |
Why?
|
Reproducibility of Results | 5 | 2021 | 20098 | 0.090 |
Why?
|
Commerce | 1 | 2016 | 606 | 0.090 |
Why?
|
Paralysis | 1 | 2011 | 250 | 0.090 |
Why?
|
Promoter Regions, Genetic | 2 | 2009 | 5789 | 0.090 |
Why?
|
Monocytes | 1 | 2019 | 2570 | 0.090 |
Why?
|
Hirschsprung Disease | 1 | 1992 | 163 | 0.090 |
Why?
|
Postoperative Complications | 2 | 2010 | 15631 | 0.090 |
Why?
|
Arthritis, Reactive | 1 | 2009 | 20 | 0.080 |
Why?
|
Species Specificity | 2 | 2015 | 2414 | 0.080 |
Why?
|
Minisatellite Repeats | 1 | 2010 | 163 | 0.080 |
Why?
|
Cells, Cultured | 4 | 2013 | 18965 | 0.080 |
Why?
|
Cytokines | 5 | 2019 | 7396 | 0.080 |
Why?
|
Incontinentia Pigmenti | 1 | 2009 | 12 | 0.080 |
Why?
|
Population Density | 1 | 2010 | 193 | 0.080 |
Why?
|
Membrane Proteins | 1 | 2006 | 7856 | 0.080 |
Why?
|
Demography | 4 | 2015 | 1648 | 0.080 |
Why?
|
Breast Feeding | 1 | 2017 | 1359 | 0.080 |
Why?
|
Intestinal Diseases, Parasitic | 1 | 2009 | 64 | 0.080 |
Why?
|
Socioeconomic Factors | 2 | 2015 | 7827 | 0.080 |
Why?
|
Chromosomes, Human, Pair 20 | 1 | 2009 | 127 | 0.080 |
Why?
|
Metagenome | 2 | 2023 | 450 | 0.080 |
Why?
|
Carrier Proteins | 2 | 1999 | 4936 | 0.080 |
Why?
|
Foodborne Diseases | 1 | 2008 | 41 | 0.080 |
Why?
|
Seizures | 1 | 2021 | 2957 | 0.080 |
Why?
|
Fluid Therapy | 2 | 2012 | 579 | 0.080 |
Why?
|
Cross-Sectional Studies | 8 | 2022 | 26125 | 0.080 |
Why?
|
Macaca mulatta | 2 | 2021 | 2329 | 0.080 |
Why?
|
Floods | 1 | 2008 | 41 | 0.080 |
Why?
|
Growth Disorders | 1 | 2013 | 655 | 0.080 |
Why?
|
Fimbriae, Bacterial | 2 | 2005 | 138 | 0.080 |
Why?
|
Hygiene | 1 | 2008 | 94 | 0.080 |
Why?
|
Helminthiasis | 1 | 2009 | 81 | 0.080 |
Why?
|
Counseling | 2 | 2015 | 1547 | 0.080 |
Why?
|
Primary Prevention | 1 | 2015 | 1186 | 0.080 |
Why?
|
Microarray Analysis | 1 | 2010 | 749 | 0.070 |
Why?
|
Angiogenesis Inhibitors | 2 | 2009 | 2047 | 0.070 |
Why?
|
Bartonella | 1 | 2007 | 11 | 0.070 |
Why?
|
Pregnancy | 6 | 2023 | 29874 | 0.070 |
Why?
|
Bartonella Infections | 1 | 2007 | 21 | 0.070 |
Why?
|
Toxoids | 1 | 2007 | 11 | 0.070 |
Why?
|
Rotavirus | 1 | 2008 | 109 | 0.070 |
Why?
|
Diagnostic Tests, Routine | 1 | 2013 | 787 | 0.070 |
Why?
|
Fluorescent Dyes | 1 | 2015 | 1903 | 0.070 |
Why?
|
Neovascularization, Pathologic | 2 | 2009 | 2645 | 0.070 |
Why?
|
Proteins | 2 | 2013 | 6032 | 0.070 |
Why?
|
World Health Organization | 1 | 2013 | 1322 | 0.070 |
Why?
|
DNA, Complementary | 1 | 2010 | 1991 | 0.070 |
Why?
|
Multivariate Analysis | 5 | 2014 | 12059 | 0.070 |
Why?
|
Lymph Nodes | 1 | 2019 | 3466 | 0.070 |
Why?
|
Carcinoma, Signet Ring Cell | 1 | 2007 | 82 | 0.070 |
Why?
|
Primaquine | 1 | 2006 | 28 | 0.070 |
Why?
|
Conjunctiva | 1 | 2010 | 479 | 0.070 |
Why?
|
Pregnancy Complications, Infectious | 2 | 2017 | 2151 | 0.070 |
Why?
|
Tropical Medicine | 2 | 2004 | 51 | 0.070 |
Why?
|
Schistosoma mansoni | 1 | 2007 | 155 | 0.070 |
Why?
|
Lovastatin | 1 | 2006 | 115 | 0.070 |
Why?
|
Length of Stay | 1 | 2000 | 6425 | 0.070 |
Why?
|
Telemedicine | 1 | 2024 | 3051 | 0.070 |
Why?
|
Filaricides | 1 | 2005 | 10 | 0.070 |
Why?
|
Penicillin G Benzathine | 1 | 2005 | 25 | 0.070 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2018 | 3639 | 0.070 |
Why?
|
Syphilis Serodiagnosis | 1 | 2005 | 37 | 0.070 |
Why?
|
Mass Screening | 1 | 2022 | 5428 | 0.060 |
Why?
|
Shiga Toxin | 1 | 2005 | 36 | 0.060 |
Why?
|
Ivermectin | 1 | 2005 | 46 | 0.060 |
Why?
|
Advisory Committees | 2 | 2022 | 787 | 0.060 |
Why?
|
Epitopes | 2 | 2022 | 2503 | 0.060 |
Why?
|
Reagent Kits, Diagnostic | 2 | 2018 | 239 | 0.060 |
Why?
|
Th17 Cells | 3 | 2022 | 794 | 0.060 |
Why?
|
Gastritis | 1 | 2007 | 199 | 0.060 |
Why?
|
Prevalence | 4 | 2018 | 15732 | 0.060 |
Why?
|
Polymerase Chain Reaction | 4 | 2018 | 6075 | 0.060 |
Why?
|
Single-Cell Analysis | 1 | 2016 | 2449 | 0.060 |
Why?
|
Aphasia, Broca | 1 | 2005 | 52 | 0.060 |
Why?
|
Tanzania | 1 | 2010 | 1387 | 0.060 |
Why?
|
Rectum | 2 | 2009 | 892 | 0.060 |
Why?
|
Bacterial Outer Membrane Proteins | 2 | 1999 | 406 | 0.060 |
Why?
|
Indonesia | 1 | 2005 | 128 | 0.060 |
Why?
|
Bacillus | 1 | 2005 | 78 | 0.060 |
Why?
|
Empyema, Pleural | 1 | 2005 | 61 | 0.060 |
Why?
|
Sex Factors | 2 | 2017 | 10552 | 0.060 |
Why?
|
Skin | 1 | 2019 | 4484 | 0.060 |
Why?
|
Wounds and Injuries | 1 | 2018 | 2491 | 0.060 |
Why?
|
Gene Library | 2 | 2005 | 1059 | 0.060 |
Why?
|
Eye | 1 | 2009 | 712 | 0.060 |
Why?
|
Mycobacterium smegmatis | 1 | 2005 | 126 | 0.060 |
Why?
|
Retinal Detachment | 1 | 2009 | 428 | 0.060 |
Why?
|
Abnormalities, Multiple | 1 | 1992 | 1423 | 0.060 |
Why?
|
Retinopathy of Prematurity | 1 | 2009 | 439 | 0.060 |
Why?
|
Aortography | 1 | 2005 | 421 | 0.060 |
Why?
|
Decision Making | 1 | 2018 | 3929 | 0.060 |
Why?
|
Double-Blind Method | 1 | 2018 | 12341 | 0.060 |
Why?
|
Zinc | 3 | 2017 | 690 | 0.060 |
Why?
|
Disease Progression | 1 | 2020 | 13506 | 0.060 |
Why?
|
Epidemiologic Methods | 2 | 2018 | 1336 | 0.060 |
Why?
|
Boston | 2 | 2020 | 9326 | 0.050 |
Why?
|
Echinococcus | 1 | 2003 | 15 | 0.050 |
Why?
|
Retinal Vein Occlusion | 1 | 2005 | 149 | 0.050 |
Why?
|
Immunity, Cellular | 1 | 2009 | 1560 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 5 | 2021 | 20570 | 0.050 |
Why?
|
Chronic Disease | 2 | 2011 | 9318 | 0.050 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2011 | 3778 | 0.050 |
Why?
|
Signal Transduction | 2 | 2018 | 23445 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2021 | 5440 | 0.050 |
Why?
|
Retinal Vessels | 1 | 2009 | 852 | 0.050 |
Why?
|
Liver | 1 | 2019 | 7529 | 0.050 |
Why?
|
Brain Diseases | 1 | 2012 | 1545 | 0.050 |
Why?
|
Biomedical Research | 1 | 2018 | 3429 | 0.050 |
Why?
|
Trypanosoma brucei rhodesiense | 1 | 2002 | 13 | 0.050 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2017 | 3204 | 0.050 |
Why?
|
Prospective Studies | 7 | 2023 | 54425 | 0.050 |
Why?
|
Retrospective Studies | 5 | 2024 | 80636 | 0.050 |
Why?
|
Hemorrhagic Fevers, Viral | 1 | 2002 | 23 | 0.050 |
Why?
|
Antibodies | 2 | 2021 | 2418 | 0.050 |
Why?
|
Trypanosomiasis, African | 1 | 2002 | 30 | 0.050 |
Why?
|
Antacids | 1 | 2022 | 94 | 0.050 |
Why?
|
HIV-1 | 1 | 2020 | 6863 | 0.050 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2014 | 4369 | 0.050 |
Why?
|
Knowledge | 1 | 2024 | 177 | 0.050 |
Why?
|
Radiography | 2 | 2011 | 6965 | 0.050 |
Why?
|
Information Dissemination | 1 | 2010 | 1126 | 0.050 |
Why?
|
beta-Lactams | 1 | 2023 | 155 | 0.050 |
Why?
|
ROC Curve | 2 | 2021 | 3579 | 0.050 |
Why?
|
Patient Education as Topic | 1 | 2012 | 2319 | 0.050 |
Why?
|
Central Nervous System Infections | 1 | 2002 | 61 | 0.050 |
Why?
|
DNA, Bacterial | 3 | 2014 | 1479 | 0.050 |
Why?
|
Pneumothorax | 1 | 2005 | 385 | 0.050 |
Why?
|
Th1 Cells | 3 | 2012 | 1036 | 0.050 |
Why?
|
Azithromycin | 1 | 2023 | 199 | 0.050 |
Why?
|
Systems Analysis | 1 | 2022 | 169 | 0.050 |
Why?
|
Poverty | 1 | 2013 | 2698 | 0.050 |
Why?
|
Phosphoproteins | 2 | 2020 | 2448 | 0.050 |
Why?
|
Emergency Service, Hospital | 1 | 2021 | 7879 | 0.050 |
Why?
|
Th2 Cells | 3 | 2012 | 1060 | 0.050 |
Why?
|
Evolution, Molecular | 2 | 2022 | 1886 | 0.050 |
Why?
|
Cell Proliferation | 3 | 2015 | 10445 | 0.050 |
Why?
|
Seroepidemiologic Studies | 1 | 2022 | 397 | 0.050 |
Why?
|
Carbohydrates | 1 | 2023 | 390 | 0.050 |
Why?
|
Optic Nerve | 1 | 2005 | 572 | 0.050 |
Why?
|
Longitudinal Studies | 3 | 2022 | 14605 | 0.050 |
Why?
|
Biopsy | 3 | 2019 | 6766 | 0.050 |
Why?
|
Microbial Interactions | 1 | 2021 | 74 | 0.050 |
Why?
|
Combined Modality Therapy | 2 | 2014 | 8529 | 0.050 |
Why?
|
Chromatography, High Pressure Liquid | 2 | 2019 | 1541 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 4 | 2013 | 17904 | 0.050 |
Why?
|
Environmental Exposure | 2 | 2013 | 4486 | 0.050 |
Why?
|
Binding Sites, Antibody | 1 | 2021 | 337 | 0.050 |
Why?
|
Polymorphism, Genetic | 1 | 2011 | 4243 | 0.050 |
Why?
|
Health Surveys | 1 | 2010 | 4061 | 0.040 |
Why?
|
Drug Resistance, Microbial | 1 | 2023 | 825 | 0.040 |
Why?
|
Intubation | 1 | 2020 | 139 | 0.040 |
Why?
|
Abdominal Pain | 2 | 2019 | 1071 | 0.040 |
Why?
|
CD4 Lymphocyte Count | 2 | 2017 | 2571 | 0.040 |
Why?
|
Africa | 2 | 2018 | 709 | 0.040 |
Why?
|
Asymptomatic Infections | 1 | 2021 | 131 | 0.040 |
Why?
|
Vaccines, Subunit | 1 | 2000 | 161 | 0.040 |
Why?
|
Health Personnel | 1 | 2014 | 3335 | 0.040 |
Why?
|
Sodium Acetate | 1 | 2019 | 7 | 0.040 |
Why?
|
HL-60 Cells | 1 | 2020 | 363 | 0.040 |
Why?
|
Databases, Factual | 2 | 2013 | 7967 | 0.040 |
Why?
|
Preoperative Care | 1 | 2009 | 2242 | 0.040 |
Why?
|
Limit of Detection | 1 | 2020 | 273 | 0.040 |
Why?
|
Colony Count, Microbial | 2 | 2012 | 330 | 0.040 |
Why?
|
Blood Chemical Analysis | 1 | 2021 | 437 | 0.040 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2022 | 422 | 0.040 |
Why?
|
Drug Resistance, Multiple | 1 | 2001 | 255 | 0.040 |
Why?
|
Lipid A | 1 | 2019 | 70 | 0.040 |
Why?
|
Public Health | 1 | 2012 | 2669 | 0.040 |
Why?
|
Macaca fascicularis | 1 | 2021 | 903 | 0.040 |
Why?
|
Carbohydrate Conformation | 1 | 2019 | 206 | 0.040 |
Why?
|
Awareness | 1 | 2023 | 648 | 0.040 |
Why?
|
Genetic Complementation Test | 1 | 2000 | 554 | 0.040 |
Why?
|
Health Status | 1 | 2012 | 4077 | 0.040 |
Why?
|
Inflammasomes | 2 | 2015 | 526 | 0.040 |
Why?
|
Eosinophils | 1 | 2004 | 950 | 0.040 |
Why?
|
Plasmodium vivax | 1 | 2001 | 202 | 0.040 |
Why?
|
Models, Biological | 2 | 2019 | 9469 | 0.040 |
Why?
|
Brain | 2 | 2021 | 27112 | 0.040 |
Why?
|
Endotoxins | 1 | 2021 | 520 | 0.040 |
Why?
|
Biotechnology | 1 | 2020 | 282 | 0.040 |
Why?
|
Delivery of Health Care | 2 | 2015 | 5336 | 0.040 |
Why?
|
Culture Media | 1 | 2020 | 897 | 0.040 |
Why?
|
Immunoblotting | 1 | 2021 | 1646 | 0.040 |
Why?
|
Endometriosis | 1 | 2006 | 870 | 0.040 |
Why?
|
Hydrolysis | 1 | 2019 | 664 | 0.040 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 1 | 2019 | 266 | 0.040 |
Why?
|
Disease Notification | 1 | 2018 | 95 | 0.040 |
Why?
|
Sudan | 1 | 2018 | 86 | 0.040 |
Why?
|
Gene Expression Regulation | 3 | 2019 | 11903 | 0.040 |
Why?
|
Africa South of the Sahara | 1 | 2001 | 744 | 0.040 |
Why?
|
Transgenes | 1 | 2021 | 1010 | 0.040 |
Why?
|
Aorta | 1 | 2005 | 2042 | 0.040 |
Why?
|
Cryoelectron Microscopy | 1 | 2022 | 650 | 0.040 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2019 | 3769 | 0.040 |
Why?
|
Sequence Analysis, DNA | 3 | 2015 | 4740 | 0.040 |
Why?
|
Physical Examination | 1 | 2004 | 1255 | 0.040 |
Why?
|
Odds Ratio | 3 | 2021 | 9646 | 0.040 |
Why?
|
Mice, Inbred C57BL | 3 | 2021 | 22169 | 0.040 |
Why?
|
Viremia | 1 | 2020 | 707 | 0.040 |
Why?
|
Massachusetts | 2 | 2020 | 8830 | 0.040 |
Why?
|
Family | 3 | 2015 | 3194 | 0.040 |
Why?
|
Dyspnea | 1 | 2005 | 1347 | 0.040 |
Why?
|
Protein Subunits | 1 | 2020 | 943 | 0.040 |
Why?
|
Stomach Neoplasms | 1 | 2007 | 1459 | 0.040 |
Why?
|
Americas | 1 | 2017 | 111 | 0.040 |
Why?
|
Gene Transfer, Horizontal | 1 | 2017 | 145 | 0.040 |
Why?
|
Crystallography, X-Ray | 1 | 2022 | 1990 | 0.040 |
Why?
|
Consciousness Disorders | 1 | 2021 | 441 | 0.030 |
Why?
|
CD40 Ligand | 1 | 2018 | 522 | 0.030 |
Why?
|
Biostatistics | 1 | 2018 | 164 | 0.030 |
Why?
|
Specialization | 1 | 2021 | 778 | 0.030 |
Why?
|
Glutamine | 1 | 2000 | 577 | 0.030 |
Why?
|
Hybridomas | 1 | 2017 | 442 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2022 | 15500 | 0.030 |
Why?
|
Immunoglobulins | 2 | 2017 | 853 | 0.030 |
Why?
|
Dependovirus | 1 | 2021 | 718 | 0.030 |
Why?
|
Water | 1 | 2022 | 1411 | 0.030 |
Why?
|
Molecular Sequence Data | 3 | 2015 | 17635 | 0.030 |
Why?
|
Genes, Bacterial | 1 | 2000 | 1073 | 0.030 |
Why?
|
Synteny | 1 | 2015 | 77 | 0.030 |
Why?
|
Oxides | 1 | 2017 | 401 | 0.030 |
Why?
|
Models, Animal | 1 | 2002 | 2112 | 0.030 |
Why?
|
Age Distribution | 2 | 2014 | 2880 | 0.030 |
Why?
|
Gene Order | 1 | 2015 | 169 | 0.030 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2021 | 621 | 0.030 |
Why?
|
Mutation | 3 | 2022 | 30052 | 0.030 |
Why?
|
Fluorescence Polarization | 1 | 2015 | 140 | 0.030 |
Why?
|
Tryptophan-tRNA Ligase | 1 | 2015 | 16 | 0.030 |
Why?
|
Vitamin A | 2 | 2008 | 613 | 0.030 |
Why?
|
Bacteria | 1 | 2006 | 2199 | 0.030 |
Why?
|
Polysaccharides | 1 | 2022 | 1014 | 0.030 |
Why?
|
Lymphoproliferative Disorders | 1 | 2019 | 531 | 0.030 |
Why?
|
Interleukin-12 Subunit p40 | 1 | 2015 | 57 | 0.030 |
Why?
|
Computer Simulation | 2 | 2019 | 6240 | 0.030 |
Why?
|
Mutagenesis | 1 | 1999 | 1232 | 0.030 |
Why?
|
Immunity | 1 | 2021 | 996 | 0.030 |
Why?
|
Area Under Curve | 1 | 2019 | 1638 | 0.030 |
Why?
|
Amino Acid Sequence | 2 | 2020 | 13446 | 0.030 |
Why?
|
Organ Transplantation | 1 | 2005 | 1157 | 0.030 |
Why?
|
Calgranulin A | 1 | 2015 | 80 | 0.030 |
Why?
|
Spirometry | 1 | 2017 | 929 | 0.030 |
Why?
|
Comorbidity | 2 | 2020 | 10508 | 0.030 |
Why?
|
Survival Analysis | 2 | 2018 | 10090 | 0.030 |
Why?
|
Adaptive Immunity | 1 | 2019 | 726 | 0.030 |
Why?
|
Muscle Strength | 1 | 2018 | 624 | 0.030 |
Why?
|
Malabsorption Syndromes | 1 | 2014 | 135 | 0.030 |
Why?
|
Age of Onset | 1 | 2021 | 3305 | 0.030 |
Why?
|
Temperature | 1 | 2020 | 2226 | 0.030 |
Why?
|
Bacterial Load | 1 | 2014 | 152 | 0.030 |
Why?
|
Micronutrients | 1 | 2016 | 382 | 0.030 |
Why?
|
Africa, Western | 1 | 2013 | 159 | 0.030 |
Why?
|
Referral and Consultation | 2 | 2017 | 3600 | 0.030 |
Why?
|
Computational Biology | 1 | 2005 | 3518 | 0.030 |
Why?
|
Yellow fever virus | 1 | 2013 | 23 | 0.030 |
Why?
|
Microspheres | 1 | 2016 | 784 | 0.030 |
Why?
|
Parasites | 1 | 1996 | 160 | 0.030 |
Why?
|
Sarcoidosis | 1 | 2019 | 521 | 0.030 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2017 | 432 | 0.030 |
Why?
|
Genotype | 3 | 2015 | 12990 | 0.030 |
Why?
|
RNA | 1 | 2023 | 2726 | 0.030 |
Why?
|
Uganda | 1 | 2017 | 1332 | 0.030 |
Why?
|
Hot Temperature | 1 | 2019 | 1440 | 0.030 |
Why?
|
Nutritional Status | 1 | 2021 | 1615 | 0.030 |
Why?
|
Forced Expiratory Volume | 1 | 2017 | 1814 | 0.030 |
Why?
|
Asymptomatic Diseases | 1 | 2015 | 588 | 0.030 |
Why?
|
Ultrasonography | 1 | 2005 | 5972 | 0.030 |
Why?
|
Reticulocytes | 1 | 2013 | 289 | 0.030 |
Why?
|
Point Mutation | 1 | 2017 | 1595 | 0.030 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2017 | 2496 | 0.030 |
Why?
|
Radiography, Thoracic | 1 | 2019 | 1302 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2024 | 3575 | 0.020 |
Why?
|
Logistic Models | 3 | 2012 | 13255 | 0.020 |
Why?
|
RNA, Viral | 1 | 2020 | 2846 | 0.020 |
Why?
|
Cryptosporidium parvum | 1 | 2012 | 35 | 0.020 |
Why?
|
Genomics | 2 | 2018 | 5821 | 0.020 |
Why?
|
Altruism | 1 | 2014 | 208 | 0.020 |
Why?
|
Cell Separation | 1 | 2017 | 1720 | 0.020 |
Why?
|
Friends | 1 | 2013 | 149 | 0.020 |
Why?
|
Guidelines as Topic | 1 | 2018 | 1386 | 0.020 |
Why?
|
Health Policy | 1 | 2024 | 2684 | 0.020 |
Why?
|
Anticonvulsants | 1 | 2021 | 1906 | 0.020 |
Why?
|
Models, Molecular | 1 | 2022 | 5439 | 0.020 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 2014 | 506 | 0.020 |
Why?
|
Birth Order | 1 | 1992 | 95 | 0.020 |
Why?
|
Pedigree | 2 | 2009 | 4542 | 0.020 |
Why?
|
Occupations | 1 | 2013 | 515 | 0.020 |
Why?
|
Cattle | 1 | 2017 | 3849 | 0.020 |
Why?
|
Follow-Up Studies | 4 | 2014 | 39106 | 0.020 |
Why?
|
Toll-Like Receptor 4 | 1 | 2015 | 579 | 0.020 |
Why?
|
Kinetics | 1 | 2019 | 6374 | 0.020 |
Why?
|
Paneth Cells | 1 | 2011 | 98 | 0.020 |
Why?
|
Interleukin-10 | 1 | 2016 | 1175 | 0.020 |
Why?
|
Flow Cytometry | 2 | 2013 | 5869 | 0.020 |
Why?
|
Public Health Informatics | 1 | 2011 | 109 | 0.020 |
Why?
|
Myocardial Infarction | 1 | 1992 | 11460 | 0.020 |
Why?
|
False Positive Reactions | 1 | 2013 | 957 | 0.020 |
Why?
|
Serine Endopeptidases | 1 | 2016 | 1022 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2020 | 3208 | 0.020 |
Why?
|
DNA, Protozoan | 1 | 2011 | 228 | 0.020 |
Why?
|
Diet | 1 | 2008 | 8075 | 0.020 |
Why?
|
Intestine, Small | 2 | 2007 | 1206 | 0.020 |
Why?
|
Morbidity | 1 | 1996 | 1750 | 0.020 |
Why?
|
Prognosis | 2 | 2021 | 29625 | 0.020 |
Why?
|
Nigeria | 1 | 2013 | 770 | 0.020 |
Why?
|
Erythromycin | 1 | 2010 | 115 | 0.020 |
Why?
|
HLA-B27 Antigen | 1 | 2009 | 63 | 0.020 |
Why?
|
DNA | 1 | 2023 | 7212 | 0.020 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2011 | 296 | 0.020 |
Why?
|
Protein Binding | 1 | 2022 | 9351 | 0.020 |
Why?
|
Tetracycline | 1 | 2010 | 216 | 0.020 |
Why?
|
Pilot Projects | 1 | 2022 | 8631 | 0.020 |
Why?
|
Iron | 1 | 2017 | 1793 | 0.020 |
Why?
|
Neutrophils | 1 | 2022 | 3767 | 0.020 |
Why?
|
Rare Diseases | 1 | 2014 | 622 | 0.020 |
Why?
|
Hypergammaglobulinemia | 1 | 1988 | 71 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2020 | 3826 | 0.020 |
Why?
|
Maternal Age | 1 | 1992 | 809 | 0.020 |
Why?
|
Cost of Illness | 1 | 2018 | 1936 | 0.020 |
Why?
|
Selection, Genetic | 1 | 2013 | 868 | 0.020 |
Why?
|
Spectrophotometry, Atomic | 1 | 2008 | 82 | 0.020 |
Why?
|
Recurrence | 2 | 2014 | 8465 | 0.020 |
Why?
|
Serum | 1 | 2009 | 209 | 0.020 |
Why?
|
Treatment Outcome | 4 | 2019 | 64680 | 0.020 |
Why?
|
Gaucher Disease | 1 | 1988 | 110 | 0.020 |
Why?
|
Lymphocytosis | 1 | 1988 | 121 | 0.020 |
Why?
|
Internet | 1 | 2000 | 3092 | 0.020 |
Why?
|
Bacteriolysis | 1 | 2007 | 50 | 0.020 |
Why?
|
Sequence Alignment | 1 | 2012 | 2180 | 0.020 |
Why?
|
Electrophoresis | 1 | 2007 | 227 | 0.020 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2005 | 4575 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2020 | 3745 | 0.020 |
Why?
|
Causality | 1 | 2013 | 1242 | 0.020 |
Why?
|
Autoantigens | 1 | 2011 | 891 | 0.020 |
Why?
|
Gene Expression | 1 | 2000 | 7581 | 0.020 |
Why?
|
Splenomegaly | 1 | 2007 | 189 | 0.020 |
Why?
|
Biological Evolution | 1 | 2012 | 1071 | 0.020 |
Why?
|
Serum Bactericidal Test | 1 | 2005 | 3 | 0.020 |
Why?
|
Societies | 1 | 2006 | 108 | 0.020 |
Why?
|
Emigrants and Immigrants | 1 | 2012 | 543 | 0.020 |
Why?
|
Electroencephalography | 1 | 2021 | 6225 | 0.020 |
Why?
|
Protein Biosynthesis | 1 | 2013 | 2113 | 0.020 |
Why?
|
Chromatography, Gas | 1 | 2005 | 151 | 0.020 |
Why?
|
Practice Guidelines as Topic | 3 | 2014 | 7390 | 0.020 |
Why?
|
Sleep | 1 | 2021 | 4768 | 0.020 |
Why?
|
Blotting, Western | 1 | 2013 | 5035 | 0.020 |
Why?
|
Glucosephosphate Dehydrogenase | 1 | 2006 | 210 | 0.020 |
Why?
|
Chest Pain | 1 | 1992 | 1091 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15266 | 0.010 |
Why?
|
NF-kappa B | 1 | 2013 | 2490 | 0.010 |
Why?
|
Bacterial Capsules | 1 | 2005 | 244 | 0.010 |
Why?
|
Military Personnel | 1 | 2013 | 1246 | 0.010 |
Why?
|
Base Sequence | 1 | 2015 | 12441 | 0.010 |
Why?
|
Mucins | 1 | 2007 | 568 | 0.010 |
Why?
|
Peptide Fragments | 1 | 2017 | 5112 | 0.010 |
Why?
|
Bacteriophages | 1 | 2007 | 378 | 0.010 |
Why?
|
Cluster Analysis | 1 | 2011 | 2707 | 0.010 |
Why?
|
Guideline Adherence | 1 | 2014 | 2220 | 0.010 |
Why?
|
Linkage Disequilibrium | 1 | 2009 | 1998 | 0.010 |
Why?
|
Immunosorbent Techniques | 1 | 2003 | 175 | 0.010 |
Why?
|
Birth Weight | 1 | 1992 | 2103 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2018 | 4948 | 0.010 |
Why?
|
Hemagglutinins | 1 | 2003 | 113 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 2007 | 13380 | 0.010 |
Why?
|
Mice, Inbred Strains | 1 | 2005 | 1762 | 0.010 |
Why?
|
Sex Distribution | 1 | 2008 | 2281 | 0.010 |
Why?
|
Gestational Age | 1 | 1992 | 3577 | 0.010 |
Why?
|
Suramin | 1 | 2002 | 34 | 0.010 |
Why?
|
Compartment Syndromes | 1 | 2005 | 159 | 0.010 |
Why?
|
Transplantation Immunology | 1 | 2005 | 532 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2015 | 4174 | 0.010 |
Why?
|
Microscopy | 1 | 2007 | 903 | 0.010 |
Why?
|
Mannose-Binding Lectin | 1 | 2003 | 145 | 0.010 |
Why?
|
Trypanocidal Agents | 1 | 2002 | 41 | 0.010 |
Why?
|
Foot Dermatoses | 1 | 2002 | 47 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2011 | 2735 | 0.010 |
Why?
|
Multigene Family | 1 | 2005 | 1076 | 0.010 |
Why?
|
Anthrax | 1 | 2002 | 87 | 0.010 |
Why?
|
Gene Frequency | 1 | 2009 | 3606 | 0.010 |
Why?
|
Skin Diseases, Bacterial | 1 | 2002 | 68 | 0.010 |
Why?
|
Virulence Factors | 1 | 2005 | 513 | 0.010 |
Why?
|
Drug Design | 1 | 2006 | 1048 | 0.010 |
Why?
|
Erythema | 1 | 2002 | 262 | 0.010 |
Why?
|
Inflammation | 1 | 2020 | 10773 | 0.010 |
Why?
|
Spinal Puncture | 1 | 2002 | 282 | 0.010 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2014 | 4580 | 0.010 |
Why?
|
Animals, Newborn | 1 | 2005 | 2678 | 0.010 |
Why?
|
Decompression, Surgical | 1 | 2005 | 607 | 0.010 |
Why?
|
Metronidazole | 1 | 2001 | 232 | 0.010 |
Why?
|
Cerebrospinal Fluid | 1 | 2002 | 544 | 0.010 |
Why?
|
Enterocolitis, Pseudomembranous | 1 | 2001 | 264 | 0.010 |
Why?
|
Models, Statistical | 1 | 2013 | 5079 | 0.010 |
Why?
|
Apoptosis | 1 | 2015 | 9486 | 0.010 |
Why?
|
Electrocardiography | 1 | 1992 | 6377 | 0.010 |
Why?
|
Pharmaceutical Preparations | 1 | 2006 | 1089 | 0.010 |
Why?
|
Cataract Extraction | 1 | 2002 | 467 | 0.010 |
Why?
|
Necrosis | 1 | 2002 | 1611 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2011 | 11076 | 0.010 |
Why?
|
Vancomycin | 1 | 2001 | 503 | 0.010 |
Why?
|
Alleles | 1 | 2009 | 6863 | 0.010 |
Why?
|
Anemia | 1 | 2007 | 1509 | 0.010 |
Why?
|
Antibiotic Prophylaxis | 1 | 2002 | 636 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2005 | 4615 | 0.010 |
Why?
|
Vero Cells | 1 | 1997 | 482 | 0.010 |
Why?
|
Patient Compliance | 1 | 2006 | 2690 | 0.010 |
Why?
|
Risk | 1 | 2007 | 9610 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2006 | 10766 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2021 | 36426 | 0.010 |
Why?
|
Colon | 1 | 2001 | 1792 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2012 | 15936 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2006 | 8002 | 0.010 |
Why?
|
Aging | 1 | 2008 | 8708 | 0.010 |
Why?
|
Blotting, Southern | 1 | 1988 | 777 | 0.000 |
Why?
|
DNA-Binding Proteins | 1 | 2003 | 9606 | 0.000 |
Why?
|